Universe Pharmaceuticals (UPC) Receivables - Other (2021 - 2026)
Universe Pharmaceuticals (UPC) posted Receivables - Other of $7.2 million for Q1 2026, up 214.85% sequentially from $2.3 million in Q3 2025.
Universe Pharmaceuticals (UPC) Receivables - Other (2021 - 2026) Analysis & Trends
Universe Pharmaceuticals has reported Receivables - Other for 6 years, with the latest figure at $7.2 million in Q1 2026.
- Quarterly Receivables - Other changed N/A year-over-year to $7.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.2 million (changed N/A YoY) and the FY2025 annual result came in at -$3.3 billion, down 158.23% from the prior year.
- Receivables - Other advanced to $7.2 million in Q1 2026 per UPC's latest filing, from $2.3 million in the prior quarter.
- Over five years, Receivables - Other peaked at $5.7 billion in Q3 2024 and troughed at $356290.0 in Q1 2022.
- A 5-year average of $1.1 billion and a median of $2.3 million in 2025 frame the typical range for Receivables - Other.
- The sharpest annual moves came in 2024 and 2025: Receivables - Other surged 294996.63% in 2024, then plunged 99.96% in 2025.
- Over 5 years, Receivables - Other stood at $356290.0 in 2022, then jumped by 438.96% to $1.9 million in 2023, then soared by 294996.63% to $5.7 billion in 2024, then slumped by 99.96% to $2.3 million in 2025, then soared by 214.85% to $7.2 million in 2026.
- According to Business Quant data, Receivables - Other over the past three periods registered $7.2 million, $2.3 million, and $5.7 billion for Q1 2026, Q3 2025, and Q3 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.31 Bn | 43.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.73 Bn | 40.08 Bn | 2.15 Bn |
| 3 | Zoetis | 32.22 Bn | 30.55 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.70 Bn | 22.90 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.34 Bn | 19.68 Bn | 683.80 Mn |
| 6 | Viatris | 18.89 Bn | 18.00 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.98 Bn | 11.45 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Universe Pharmaceuticals | 2.91 Mn | -26.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.18 Mn |
| Mar 31, 2026 | 7.18 Mn |
| Sep 30, 2025 | 2.28 Mn |
| Sep 30, 2025 | 2.28 Mn |
| Sep 30, 2024 | 5.67 Bn |
| Sep 30, 2024 | 5.67 Bn |
| Sep 30, 2023 | 1.92 Mn |
| Sep 30, 2023 | 1.92 Mn |
| Mar 31, 2022 | 356,290.00 |
| Mar 31, 2022 | 356,290.00 |
| Sep 30, 2021 | 236,982.00 |
| Sep 30, 2021 | 236,982.00 |